12117 BEE CAVES ROAD BUILDING THREE, AUSTIN, TX
Amended material disclosure
Michael Buhle Departs as CEO; John Fraser Appointed Interim CEO
Election of Directors at Aspira Women’s Health Inc. Annual Meeting
Aspira Women’s Health Inc. Completes $1.485M Private Placement
Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women’s Health
Aspira Women’s Health Inc. Enters $1.05M Subordinated Loan Agreement
Investor Presentation
Material Contracts, Unregistered Sales of Equity Securities
Q1
Notice of Late Filing for Annual Report
FY 2025
Q3
Q2
Notice of Late Filing for Quarterly Report
FY 2024
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Amended Registration Statement for Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Definitive Revised Proxy Statement